TFA Therapeutics, Inc. (RAJAF) stock
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$9.18+0.00 (0.00%)
Close on Oct 16, 2026Market cap –P/E –Yield –
TFA Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
TFA Therapeutics's enterprise value was $1.02B on Oct 16, 2026, against $1.02B a year earlier. Over the last 2 years it ranged from $4.85M to $1.02B, with a median of $1.02B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 16, 2026 | $1.02B | +0.0% |
| 2025 | Dec 31, 2025 | $1.02B | +11.2% |
| 2024 | Dec 31, 2024 | $917.15M | – |
See a number that looks wrong?